DESIREE LONG: Open Payments
NPI 1508167644 · NORTH SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$680 in 26 payments from 13 companies in 2025. Trend: 2023 $131 · 2024 $308 · 2025 $680
Food & beverage: $680
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $146 |
| Supernus Pharmaceuticals, Inc. | 2 | $108 |
| UCB, Inc. | 3 | $86 |
| CATALYST PHARMACEUTICALS, INC. | 3 | $77 |
| SK Life Science, Inc. | 2 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $53 |
| Lundbeck LLC | 2 | $38 |
| ARGENX US, INC. | 1 | $25 |
| Merz Pharmaceuticals, LLC | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $19 |
Products named: Qelbree, QULIPTA, FIRDAPSE, UBRELVY, HYQVIA, VYEPTI, Briviact, Rystiggo.
Industry payments across NY — which companies pay providers there.
